Cargando…
Coronavirus glycoprotein E1, a new type of viral glycoprotein()
The carbohydrate contents of coronavirus glycoproteins E1 and E2 have been analyzed. E2 has complex and mannose-rich-type oligosaccharide side-chains, which are attached by N-glycosidic linkages to the polypeptide. Glycosylation of E2 is initiated at the co-translational level, and it is inhibited b...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130891/ https://www.ncbi.nlm.nih.gov/pubmed/7343686 http://dx.doi.org/10.1016/0022-2836(81)90463-0 |
_version_ | 1783517113738067968 |
---|---|
author | Niemann, H. Klenk, H.-D. |
author_facet | Niemann, H. Klenk, H.-D. |
author_sort | Niemann, H. |
collection | PubMed |
description | The carbohydrate contents of coronavirus glycoproteins E1 and E2 have been analyzed. E2 has complex and mannose-rich-type oligosaccharide side-chains, which are attached by N-glycosidic linkages to the polypeptide. Glycosylation of E2 is initiated at the co-translational level, and it is inhibited by tunicamycin, 2-deoxy-glucose, and 2-deoxy-2-fluoro-glucose. Thus, E2 belongs to a glycoprotein type found in many other enveloped viruses. E1, in contrast, represents a different class of glycoprotein. The following observations indicate that its carbohydrate side-chains have 0-glycosidic linkage. (1) The constituent sugars of E1 are N-acetylglucosamine, N-acetylgalactosamine, galactose, and neuraminic acid; mannose and fucose are absent. (2) The side-chains can be removed by β-elimination. (3) Glycosylation of E1 is not sensitive to the compounds interfering with N-glycosylation. E1 is the first viral glycoprotein analyzed that contains only 0-glycosidic linkages. Coronaviruses are therefore a suitable model system to study biosynthesis and processing of this type of glycoprotein. |
format | Online Article Text |
id | pubmed-7130891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1981 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71308912020-04-08 Coronavirus glycoprotein E1, a new type of viral glycoprotein() Niemann, H. Klenk, H.-D. J Mol Biol Article The carbohydrate contents of coronavirus glycoproteins E1 and E2 have been analyzed. E2 has complex and mannose-rich-type oligosaccharide side-chains, which are attached by N-glycosidic linkages to the polypeptide. Glycosylation of E2 is initiated at the co-translational level, and it is inhibited by tunicamycin, 2-deoxy-glucose, and 2-deoxy-2-fluoro-glucose. Thus, E2 belongs to a glycoprotein type found in many other enveloped viruses. E1, in contrast, represents a different class of glycoprotein. The following observations indicate that its carbohydrate side-chains have 0-glycosidic linkage. (1) The constituent sugars of E1 are N-acetylglucosamine, N-acetylgalactosamine, galactose, and neuraminic acid; mannose and fucose are absent. (2) The side-chains can be removed by β-elimination. (3) Glycosylation of E1 is not sensitive to the compounds interfering with N-glycosylation. E1 is the first viral glycoprotein analyzed that contains only 0-glycosidic linkages. Coronaviruses are therefore a suitable model system to study biosynthesis and processing of this type of glycoprotein. Published by Elsevier Ltd. 1981-12-25 2004-10-25 /pmc/articles/PMC7130891/ /pubmed/7343686 http://dx.doi.org/10.1016/0022-2836(81)90463-0 Text en Copyright © 1981 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Niemann, H. Klenk, H.-D. Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title | Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title_full | Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title_fullStr | Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title_full_unstemmed | Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title_short | Coronavirus glycoprotein E1, a new type of viral glycoprotein() |
title_sort | coronavirus glycoprotein e1, a new type of viral glycoprotein() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130891/ https://www.ncbi.nlm.nih.gov/pubmed/7343686 http://dx.doi.org/10.1016/0022-2836(81)90463-0 |
work_keys_str_mv | AT niemannh coronavirusglycoproteine1anewtypeofviralglycoprotein AT klenkhd coronavirusglycoproteine1anewtypeofviralglycoprotein |